Monogenic Disorders of ROS Production and the Primary Anti-Oxidative Defense

Nana-Maria Grüning,Markus Ralser

DOI: https://doi.org/10.3390/biom14020206

IF: 6.064

2024-02-10

Biomolecules

Abstract:Oxidative stress, characterized by an imbalance between the production of reactive oxygen species (ROS) and the cellular anti-oxidant defense mechanisms, plays a critical role in the pathogenesis of various human diseases. Redox metabolism, comprising a network of enzymes and genes, serves as a crucial regulator of ROS levels and maintains cellular homeostasis. This review provides an overview of the most important human genes encoding for proteins involved in ROS generation, ROS detoxification, and production of reduced nicotinamide adenine dinucleotide phosphate (NADPH), and the genetic disorders that lead to dysregulation of these vital processes. Insights gained from studies on inherited monogenic metabolic diseases provide valuable basic understanding of redox metabolism and signaling, and they also help to unravel the underlying pathomechanisms that contribute to prevalent chronic disorders like cardiovascular disease, neurodegeneration, and cancer.

biochemistry & molecular biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore how monogenic diseases affect the production of reactive oxygen species (ROS) and the main antioxidant defense mechanisms. Specifically, the paper focuses on diseases caused by genetic defects in human genes encoding proteins involved in ROS generation, ROS detoxification, and reduced nicotinamide adenine dinucleotide phosphate (NADPH) production. These defects may lead to abnormally elevated or decreased ROS levels, which in turn affect the intracellular redox balance and trigger a variety of human diseases, such as cardiovascular diseases, neurodegenerative diseases, and cancer. By studying these genetic diseases, we can gain a deeper understanding of the basic mechanisms of redox metabolism and signal transduction, as well as their roles in common chronic diseases.

The key issues mentioned in the paper include:

1. **Sources of ROS**: The paper describes in detail the main sources of ROS, including the mitochondrial respiratory chain, heme in red blood cells, NADPH oxidase, and myeloperoxidase. Among them, the mitochondrial respiratory chain is one of the largest endogenous sources of ROS in eukaryotic cells, and although red blood cells do not have mitochondria, they are also an important source of ROS due to the interaction between the heme they carry and oxygen.

2. **Antioxidant defense system**: The paper discusses how cells combat ROS - induced damage through multiple mechanisms, including the roles of enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX), and peroxiredoxin (PRDX). These enzymes form the first - and second - line antioxidant defense systems in cells and can rapidly scavenge ROS to protect cells from oxidative stress.

3. **Mechanisms of monogenic diseases**: The paper focuses on analyzing monogenic diseases related to ROS generation and antioxidant defense, such as mitochondrial respiratory chain complex I deficiency, hemoglobinopathies (such as sickle - cell disease), and NADPH oxidase deficiency (such as chronic granulomatous disease). These diseases usually lead to abnormal ROS levels, thereby causing cell dysfunction and a variety of pathological symptoms.

Through these studies, the paper aims to reveal the impact of monogenic diseases on ROS generation and antioxidant defense, provide a theoretical basis for understanding the pathogenesis of these diseases, and offer potential targets for the development of new treatment strategies.